February 02, 2023
Manufacturing
36
01
Alternative approaches to freeze drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
January 02, 2023
Cover Story
36
01
This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.
January 02, 2023
Special Coverage
36
01
Cautiously setting aside pandemic practices, pharma workers appear ready for flux, change, evolution, and expanding molecular diversity.
January 02, 2023
Peer-Reviewed Research
36
01
The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.
January 02, 2023
Downstream Processing
36
01
Affinity chromatography resins must perform well under mild elution conditions yet withstand robust cleaning and sanitization protocols.
January 01, 2023
Supply Chain
36
01
Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.
January 01, 2023
Analytics
36
01
Biologic drug development requires relevant bioassays to measure and help predict cellular response.
January 01, 2023
Regulatory Beat
36
01
Politics and drug shortages will continue to impact FDA and drug manufacturers in 2023.
January 01, 2023
Ask The Expert
36
01
A CCS provides significant benefits to the industry and helps with holistically understanding contamination controls, says Siegfried Schmitt, vice president, Technical at Parexel.
January 01, 2023
From the Editor
36
01
Coverage of COVID-19 vaccines was surprisingly displaced by this year’s astounding oncology and iconoclastic gene therapy “cures.”
January 01, 2023
From the CEO
36
01
Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.